Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative and postoperative hyperkalaemia after total parathyroidectomy following exposure to cinacalcet in sixteen patients for renal hyperparathyroidism.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017
Same author

Posttraumatic lower extremity reconstruction by vascularized bone graft transfer.

Orthopedics·2014
Same author

Somatic embryogenesis and plant regeneration from zygotic embryo explants in mexican weeping bamboo, Otatea acuminata aztecorum.

Plant cell reports·2013
Same author

Simultaneous mastopexy in patients undergoing prophylactic nipple-sparing mastectomies and immediate reconstruction.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2013
Same author

Acute thyroiditis caused by Streptococcus agalactiae.

Internal medicine journal·2002
Same author

Re: Tuberous breast deformity: principles and practice.

Annals of plastic surgery·2002
Same journal

Response to: The Cost of Matching into Plastic Surgery.

Annals of plastic surgery·2026
Same journal

Comprehensive Review of Pressure Sores: Pathophysiology, Prevention, and Surgical Management.

Annals of plastic surgery·2026
Same journal

Evaluating the Efficacy and Safety of Venous Flow-Through Flaps in Hand Reconstructive Surgery: A Systematic Review.

Annals of plastic surgery·2026
Same journal

Experimental Rat Peripheral Nerve Models: Surgical Exposures and Applications.

Annals of plastic surgery·2026
Same journal

The Cost of Matching into Plastic Surgery.

Annals of plastic surgery·2026
Same journal

Microsurgery Applications in Nonplastic Surgery Specialties.

Annals of plastic surgery·2026
See all related articles

Related Experiment Videos

Pentazocine ulceration.

G B Irons1, D J Hodgkinson, G C Chong

  • 1Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN 55901, USA.

Annals of Plastic Surgery
|April 4, 2009
PubMed
Summary
This summary is machine-generated.

Pentazocine, a potent pain reliever, can cause severe skin damage from misuse. Aggressive surgical removal and skin grafting are effective treatments for these pentazocine-induced tissue injuries.

Related Experiment Videos

Area of Science:

  • Dermatology
  • Pain Management
  • Pharmacology

Background:

  • A need exists for effective, non-addicting analgesics for intractable pain.
  • Pentazocine was introduced as a potent analgesic with lower addiction potential than morphine or meperidine.
  • Long-term use and self-administration of pentazocine have led to misuse and overuse.

Purpose of the Study:

  • To describe the characteristic tissue changes resulting from pentazocine abuse.
  • To evaluate treatment outcomes for patients with pentazocine-induced cutaneous complications.

Main Methods:

  • Case series of 14 patients presenting with complications from parenteral pentazocine abuse.
  • Clinical observation of characteristic cutaneous ulcerations, subcutaneous fibrosis, and fistulous tracts.
  • Assessment of treatment responses, comparing conservative management with surgical intervention.

Main Results:

  • Patients exhibited extensive cutaneous ulcerations, subcutaneous fibrosis, and multiple fistulous tracts.
  • Conservative treatment approaches yielded poor responses.
  • Aggressive surgical excision and split-thickness skin grafting resulted in the best outcomes.

Conclusions:

  • Parenteral pentazocine abuse can lead to severe, characteristic tissue damage.
  • Conservative management is often ineffective for these lesions.
  • Aggressive surgical debridement and reconstruction offer the most effective treatment for pentazocine-induced tissue injury.